NDTV·3 min read·medium
57 Hearings And An Unanswered Call For Affordable Drugs: Court Seeks Reply
✦AI Summary
A breast cancer patient has petitioned the Kerala High Court regarding the high cost and lack of availability of the patented drug Ribociclib. The court has requested a formal response to address the accessibility of life-saving medication.
In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
healthpolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in